Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Bavarian Nordic
  4. Bavarian Nordic — Marts 2023

Bavarian Nordic — Marts 2023

Planlagt Fastgjort Låst Flyttet Bavarian Nordic
745 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    Pensionisten
    wrote on sidst redigeret af
    #104

    @Susinvest 20:46. Det var da godt noget af en melding fra Novavax.

    1 Reply Last reply
    0
    • F Offline
      F Offline
      Fandel
      wrote on sidst redigeret af
      #105

      Godmorgen...

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #106

        Godmorgen 🙂

        1 Reply Last reply
        0
        • S Offline
          S Offline
          Stroka
          wrote on sidst redigeret af
          #107

          God morgen 🙂

          1 Reply Last reply
          0
          • V Offline
            V Offline
            Villy
            wrote on sidst redigeret af
            #108

            RSV-vaccine https://medwatch.dk/Medicinal___Biotek/article15228596.ece?utm_campaign=MedWatch Morgen&utm_content=2023-03-02&utm_medium=email&utm_source=medwatch

            1 Reply Last reply
            0
            • V Offline
              V Offline
              Villy
              wrote on sidst redigeret af
              #109

              Anbefaling fra Lau https://www.euroinvestor.dk/nyheder/lau-svenssen-5-danske-aktier-som-jeg-ville-koebe-lige-nu

              1 Reply Last reply
              0
              • W Offline
                W Offline
                WorkTrader
                wrote on sidst redigeret af
                #110

                årsrapporten https://ml-eu.globenewswire.com/Resource/Download/2840497a-a18f-4ccb-a4bc-cdc79653b72a

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  ProinvestorNEWS
                  wrote on sidst redigeret af
                  #111

                  Bavarian Nordic offentliggør årsrapport for 2022

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    ProinvestorNEWS
                    wrote on sidst redigeret af
                    #112

                    Just a moment...

                    favicon

                    (www.proinvestor.com)

                    1 Reply Last reply
                    0
                    • Cubinvest2021C Offline
                      Cubinvest2021C Offline
                      Cubinvest2021
                      wrote on sidst redigeret af
                      #113

                      …. Men ingen nyheder omkring RSV eller Covid

                      1 Reply Last reply
                      0
                      • W Offline
                        W Offline
                        WorkTrader
                        wrote on sidst redigeret af
                        #114

                        ...regner stadig med en 300 mill milestone til adaptvac så ingen ændring ift forventning om godkendelse...

                        1 Reply Last reply
                        0
                        • K Offline
                          K Offline
                          Kirt
                          wrote on sidst redigeret af
                          #115

                          Konservativ forudsigelse af 2023 omsætning og EBITDA. Ikke noget taget med, som kun er lidt sandsynlig. Det åbner muligheder for opjusteringer i løbet af året.

                          1 Reply Last reply
                          0
                          • W Offline
                            W Offline
                            WorkTrader
                            wrote on sidst redigeret af
                            #116

                            ja..alt som forventet..håber der er lidt mere i ærmet om rekrutteringen eller guidance i webkaldet kl 14...

                            1 Reply Last reply
                            0
                            • W Offline
                              W Offline
                              WorkTrader
                              wrote on sidst redigeret af
                              #117

                              men heller ingen negative overraskelser 🙂

                              1 Reply Last reply
                              0
                              • K Offline
                                K Offline
                                Kraken23
                                wrote on sidst redigeret af
                                #118

                                Læg mærke til at finaselle konsekvenser ved opkøb ikke er medregnet. Der er jo drift sf nye faciliteter og 280 medarbejdere der skal have løn. Derudover er der jo næsten ingen indtægter fra de nye vacciner. Tyder på en nedjustering når handlen går i gennem

                                1 Reply Last reply
                                0
                                • K Offline
                                  K Offline
                                  Kirt
                                  wrote on sidst redigeret af
                                  #119

                                  Hvor læser du, at der ikke er indtægter fra de nye vacciner? Jeg mener ikke, at du har ret i det?

                                  1 Reply Last reply
                                  0
                                  • Cubinvest2021C Offline
                                    Cubinvest2021C Offline
                                    Cubinvest2021
                                    wrote on sidst redigeret af
                                    #120

                                    Måske dette allerede er indregnet i deres konservativ udmelding for 2023?

                                    1 Reply Last reply
                                    0
                                    • Cubinvest2021C Offline
                                      Cubinvest2021C Offline
                                      Cubinvest2021
                                      wrote on sidst redigeret af
                                      #121

                                      Altså de nye omkostninger

                                      1 Reply Last reply
                                      0
                                      • W Offline
                                        W Offline
                                        WorkTrader
                                        wrote on sidst redigeret af
                                        #122

                                        ..står på side 23 og som vi allerede ved, "Financial implications in 2023 of the
                                        travel vaccine portfolio acquisition
                                        from Emergent BioSolutions
                                        The acquired business is expected to add approximately DKK 200 million to revenue and a loss
                                        of approximately DKK 400 million to EBITDA, not
                                        included in the current company financial guidance
                                        for 2023. "

                                        1 Reply Last reply
                                        0
                                        • K Offline
                                          K Offline
                                          Kirt
                                          wrote on sidst redigeret af
                                          #123

                                          Financial implications in 2023 of the
                                          travel vaccine portfolio acquisition
                                          from Emergent BioSolutions
                                          The acquired business is expected to add approximately DKK 200 million to revenue and a loss
                                          of approximately DKK 400 million to EBITDA, not
                                          included in the current company financial guidance
                                          for 2023.
                                          The expected loss is due to investments in the
                                          Chikungunya Phase 3 program and inclusion of
                                          necessary one-off integration costs. The financial
                                          impact from the acquired business is pending final
                                          cl

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper